Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1615219 · DCOY

Decoy Therapeutics Inc.

Filing with the SEC SEC-reporting company Houston, TX Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jan 2, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)$12.5M$5.6M
Total assets$11.1M$3M
Total liabilities$5.2M$1.5M
Stockholders’ equity$5.9M$1.5M
Cash and equivalents$10.7M$2.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Decoy Therapeutics Inc.
Formerly: Salarius Pharmaceuticals, Inc.
CIK
0001615219
Tickers
DCOY
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Houston, Texas
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 7, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 12, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 10, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 15, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 8, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 31, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 2, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 19, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 8.01, 9.01 · filed Nov 13, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 8.01, 9.01 · filed Nov 13, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Nov 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 21, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 18, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 3.02 · filed Jul 31, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 25, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.01, 3.01, 9.01 · filed Mar 28, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 21, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jan 21, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 3.02 · filed Jan 17, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Dec 27, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 16, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 13, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 22, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Mar 6, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Feb 23, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Oct 27, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 6, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 15, 2023 · filing
  • Private raise (Form D)
    Form D · items 06b · filed May 25, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 11, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 27, 2023 · filing